Q4 2019 Holdings
Filed 2020-02-14 | 67 holdings | $260.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $88.1M | 2,512,865 | 33.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $62.0M | 600,000 | 23.9% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $55.6M | 400,000 | 21.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $29.6M | 2,119,132 | 11.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $16.1M | 100,000 | 6.2% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $6.3M | 479,988 | 2.4% |
| Turning Point Therapeutics I | COM | 90041T108 | $211.6K | 3,396,650 | 0.1% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $166.9K | 816,400 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $165.2K | 1,282,392 | 0.1% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $114.7K | 2,900,000 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $109.1K | 1,990,922 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $108.4K | 2,300,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $82.7K | 2,700,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR)Call | COM | 60468T105 | $64.4K | 500,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $60.9K | 1,000,000 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $56.3K | 1,000,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $54.4K | 1,000,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR)Call | CL A | 75615P103 | $51.1K | 250,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $51.0K | 700,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $50.7K | 1,788,643 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $50.1K | 1,602,376 | 0.0% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $47.6K | 500,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $41.8K | 1,837,269 | 0.0% |
| Viela BIO Inc(VIE) | COM | 926613100 | $40.7K | 1,497,500 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $35.0K | 927,975 | 0.0% |
| Ascendis Pharma A S(ASND)Call | SPONSORED ADR | 04351P101 | $34.8K | 250,000 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $33.9K | 1,222,671 | 0.0% |
| Quotient LTD | SHS | G73268107 | $33.3K | 3,500,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $32.3K | 250,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $31.8K | 700,000 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $31.0K | 2,000,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $28.7K | 400,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $28.6K | 300,000 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $28.4K | 495,692 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $28.0K | 450,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $27.9K | 1,300,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $27.6K | 345,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN)Call | COM | G11196105 | $27.2K | 500,000 | 0.0% |
| Immunovant Inc | UNIT 12/18/2024 | 45258J201 | $26.5K | 1,080,000 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $21.5K | 1,525,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $20.9K | 100,000 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $16.9K | 858,382 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $16.4K | 740,621 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $14.4K | 687,149 | 0.0% |
| Merus N V | COM | N5749R100 | $14.1K | 1,000,000 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $13.9K | 295,600 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $13.8K | 1,000,000 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $13.5K | 4,000,000 | 0.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $12.8K | 172,300 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $12.4K | 833,400 | 0.0% |